Jane Street
ROSG

Jane Street’s Rosetta Genomics Ltd. ROSG Stock Holding History

Jane Street’s Portfolio ROSG Stock Details ROSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-5,324
Closed -$318K – 3414
2014
Q1 		$318K Buy
+5,324
New +$275K ﹤0.01% 1939

Other funds holding ROSG

BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
HCM
Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street's ROSG Position: Q2 2014 in Review

Jane Street sold out of Rosetta Genomics Ltd. (ROSG) in Q2 2014, closing a stake of 5,324 shares — an estimated $318K sold.

Jane Street first reported a position in ROSG in Q1 2014 and held it in 1 quarter. The position peaked at $318K in Q1 2014. 16 funds tracked by Wall St. Rank hold ROSG as of Q2 2014.

  • Jane Street reported no remaining Rosetta Genomics Ltd. position as of Q2 2014 after selling out during the quarter.
  • Jane Street sold 5,324 Rosetta Genomics Ltd. shares in Q2 2014, an estimated $318K.
  • Jane Street first reported a position in Rosetta Genomics Ltd. in Q1 2014 and held it in 1 quarter.
  • Jane Street's Rosetta Genomics Ltd. position peaked at $318K in Q1 2014.
  • 16 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q2 2014.

Based on Jane Street's 13F filing for Q2 2014, filed 14 Aug 2014.